Martin M. Borggrefe
Distinguished in Ventricular Tachycardia

Martin M. Borggrefe

Mannheim, BW, DE 
Distinguished in Ventricular Tachycardia
Mannheim, BW, DE 
OverviewLocationsClinical Research

Overview

Martin Borggrefe practices in Mannheim, Germany. Mr. Borggrefe is rated as a Distinguished expert by MediFind in the treatment of Ventricular Tachycardia. His top areas of expertise are Short QT Syndrome, Brugada Syndrome, Ventricular Fibrillation, Percutaneous Coronary Intervention (PCI), and Cardiac Ablation.

His clinical research consists of co-authoring 485 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 58 articles and participated in 1 clinical trial in the study of Ventricular Tachycardia.

Gender
Male

Locations

Mannheim, BW, Germany
Other Locations
Heidelberg, BW, Germany
Goettingen, NI 37075, Germany
Hamburg, HH, Germany
Berlin, BE, Germany
Salem, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Enrollment Status: Unknown
Publish Date: May 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
Vest Prevention of Early Sudden Death Trial: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator (Formerly VEST/PREDICTS)
Vest Prevention of Early Sudden Death Trial: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator (Formerly VEST/PREDICTS)
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients
Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients
Enrollment Status: Completed
Publish Date: April 29, 2019
Intervention Type: Device
View 2 Less Clinical Trials

487 Total Publications

ECG Markers of Positive Drug Challenge With Ajmaline in Patients With Brugada Syndrome.
ECG Markers of Positive Drug Challenge With Ajmaline in Patients With Brugada Syndrome.
Journal: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Borggrefe's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 9 Advanced Conditions
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile